The Human Pluripotent Stem Cell facility continuously evaluates emerging technologies and is now offering both feeder-based and feeder-free cultures in chemically defined mTeSR or in N2/B27 media. The Core is currently offering the generation of iPS cells with two transgene-free methods: 1) using episomes (based on the Yamanaka plasmids); or 2) using Sendai virus.
Ullmann 925
Scientific Director
Eric Bouhassira, Ph.D.
718.430.2188
eric.bouhassira@einsteinmed.org
Tablet Blog